TARSUS PHARMACEUTICALS INC (TARS)
US87650L1035 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -135.89M | -62.09M | -13.83M | -26.81M | -4.67M | |||
| Depreciation Amortization | 877.00K | 330.00K | 310.00K | 100.00K | 40.00K | |||
| Change In Working Capital | 306.00K | -950.00K | 1.37M | 1.46M | 490.00K | |||
| Interest Paid | 2.88M | 1.68M | N/A | N/A | N/A | |||
| Other non cash items | 17.22M | 13.69M | 15.89M | 4.12M | 480.00K | |||
| OPERATING CASH FLOW | -117.49M | -49.03M | 3.75M | -21.14M | -3.67M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -5.50M | -510.00K | -590.00K | -460.00K | -180.00K | |||
| Other Investing Activity | 146.11M | -144.12M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 140.60M | -144.63M | -590.00K | -460.00K | -180.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 10.00M | 20.00M | N/A | 0.00 | 1.99M | |||
| Stock Issued/Repurchased | 120.18M | 74.94M | 320.00K | 40.10M | 57.46M | |||
| Other Financing Activity | 0.00 | -950.00K | -300.00K | 91.67M | N/A | |||
| FINANCING CASH FLOW | 130.18M | 93.99M | 20.00K | 131.77M | 59.45M | |||
| CHANGE IN CASH | 153.29M | -99.67M | 3.18M | 110.17M | 55.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -117.49M | -49.03M | 3.75M | -21.14M | -3.67M | |||
| Capital Expenditure | -5.50M | -510.00K | -590.00K | -460.00K | -180.00K | |||
| FREE CASH FLOW | -122.99M | -49.54M | 3.16M | -21.60M | -3.85M | |||
All data in USD